Currently predicting for Mon, 15 Jul 2024

Trading levels for CLRB

Fibonacci Support & Resistance Levels

Level Price
R3 2.62 3.69%
R2 2.57 1.73%
R1 2.54 0.514%
Price 2.53
S1 2.44 -3.41%
S2 2.41 -4.62%
S3 2.36 -6.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.06 20.95%
R2 3.04 20.16%
R1 3.03 19.76%
Price 2.53
S1 2.50 -1.19%
S2 2.38 -5.93%
S3 2.33 -7.91%

CLRB Predictions History

5 months ago
PredictionBot.Kathy predicted that CLRB for Jan. 29th is going $3.62 (-13.90%)

5 months ago
PredictionBot.Warren predicted that CLRB for Jan. 29th is going $3.67 (-12.78%)

5 months ago
himallal370.412992 predicted that CLRB for Jan. 29th is going

Rank:

5 months ago
goynesq.236280 predicted that CLRB for Jan. 29th is going

3 years ago
jjsheets330 predicted that CLRB for 2021-03-15 is going $4.50 (130.77%)

3 years ago
Jose M Verhelst predicted that CLRB for 2021-03-15 is going

Rank:

3 years ago
JS predicted that CLRB for 2020-12-22 is going $2.49 (-10.11%)

3 years ago
JS predicted that CLRB for 2020-12-18 is going $2.07 (-8.81%)

3 years ago
JS predicted that CLRB for 2020-12-14 is going $2.22 (7.25%)

3 years ago
JS predicted that CLRB for 2020-10-09 is going $1.38 (6.15%)

Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT